Dihydroorotic acid derivatives, processes for their preparing and pharmaceutical composition containing them.

摘要

There are disclosed 1-Methy)-4,5-dihydroorotyl-histidyl-prolinamide or a pharmaceutically acceptable acid addition salt thereof, processes for their preparation and pharmaceutical compositions containing them. The prolinamide and the parmaceutically acceptable acid addition salts thereof are useful for the treatment of central nervous system disorder.